We are live on
!
Find out more
Alnylam Pharmaceuticals
ALNY
ALNY
260 hedge funds and large institutions have $6.22B invested in Alnylam Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 98 increasing their positions, 75 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
31% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 75
18% more capital invested
Capital invested by funds: $5.26B → $6.22B (+$960M)
13% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 39
1% more funds holding
Funds holding: 257 → 260 (+3)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
17% less call options, than puts
Call options by funds: $21M | Put options by funds: $25.4M
Holders
260
Holders Change
+3
Holders Change %
+1.17%
% of All Funds
6.82%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.18%
New
44
Increased
98
Reduced
75
Closed
39
Calls
$21M
Puts
$25.4M
Net Calls
-$4.4M
Net Calls Change
-$20.5M
Top Buyers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$187M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$38.6M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$30.9M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$14.7M |
| 5 |
SPC
Slate Path Capital
New York
|
+$12.1M |
